Molecular pathogenesis of inflammatory bowel disease: relevance for novel therapies

Author： Kannengiesser Klaus Maaser Christian Kucharzik Torsten

ISSN： 1741-0541

Source： Personalized Medicine, Vol.5, Iss.6, 2008-11, pp. : 609-626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular pathogenesis of inflammatory bowel disease: Genotypes, phenotypes and personalized medicine

By Goyette Philippe Labbé Catherine Trinh Truc T. Xavier Ramnik J. Rioux John D.

Annals of Medicine, Vol. 39, Iss. 3, 2007-01 ,pp. : 177-199

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease pathogenesis: Where are we?

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S1, 2015-03 ,pp. : 12-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Future of Molecular Approaches to Inflammatory Bowel Disease

By Kabakchiev Boyko Halder Smita Silverberg Mark S.

Molecular Diagnosis & Therapy, Vol. 13, Iss. 4, 2009-08 ,pp. : 217-223

Adis International

Access to resources Recommend Favorite

Market share and costs of biologic therapies for inflammatory bowel disease in the USA

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 364-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1031-1032

John Wiley & Sons Inc

Access to resources Recommend Favorite